🇫🇷 France Country × Condition
endometrial cancer Clinical Trials in France
Active clinical trials for endometrial cancer with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇫🇷 France
Active Trials in France (4)
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Enrollment
110 pts
Country
🇫🇷 France
Alterome Therapeutics, Inc.
View Trial → NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT05255653 Phase 2, Phase 3
Recruiting
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Enrollment
1,615 pts
Country
🇫🇷 France
Leiden University Medical Center
View Trial → NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Country
🇫🇷 France
PMV Pharmaceuticals, Inc
View Trial → Frequently Asked Questions
How many endometrial cancer clinical trials are active in France?
There are currently 4 active clinical trials for endometrial cancer with sites in France, of which 4 are actively recruiting patients.
How can I join a endometrial cancer clinical trial in France?
To join a endometrial cancer clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are endometrial cancer trials in France?
Active endometrial cancer trials in France span Phase 1, Phase 2, Phase 3, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.